TruthArchive.ai - Related Video Feed

Misinformation and disinformation are leading people to believe untrue things, especially about vaccinations. However, all vaccines distributed in Canada are safe and uncompromising. While individuals have the freedom to choose, there are no more excuses to not get vaccinated. Enforcement measures will ensure everyone is vaccinated, including incentives for travelers and restrictions for those who are not vaccinated. This approach has led to a higher vaccination rate compared to other countries. It's worth noting that unknown causes were the leading cause of death in Alberta last year.

University of Alberta Health Law professor Ubaka Gbogu highlights that politicians are undermining the authority of Chief Medical Officer of Health, Dr. Hinshaw, indicating a lack of control over the pandemic response. He suggests that decisions are being made by those without the appropriate expertise. Hinshaw, who did not respond to an interview request, stated at a recent news conference that her role is to provide policy options to the cabinet, which ultimately makes the final decisions. She expressed gratitude that her recommendations are considered. A spokesperson for Premier Kenny emphasized that it is the responsibility of elected officials to make these decisions and denied any political interference.

The Alberta government's COVID-19 response review calls for an immediate halt to modified RNA vaccines, particularly for children. The report, commissioned by Premier Danielle Smith, highlights significant data gaps regarding vaccine safety and effectiveness, citing alarming statistics from Pfizer's post-authorization trial, including over 1,200 deaths and 42,000 injuries. It criticizes the abandonment of Alberta's pandemic plan and urges a return to localized approaches. Recommendations include halting vaccine use without full risk disclosure, further research, and establishing support for vaccine-injured individuals. The review raises concerns about the lack of long-term safety data and the high risk of adverse events, particularly in young, healthy populations. It emphasizes the need for transparency and informed choice in future vaccination initiatives.

The discussion around vaccines is often oversimplified, leading to distrust in government recommendations. For instance, the hepatitis B vaccine is given to newborns, despite the disease primarily spreading through drug use and sexual contact. This raises questions about the necessity of immediate vaccination. While vaccines are generally beneficial, there should be room for individual choice and discussion. The COVID vaccine presents similar complexities, especially regarding its necessity for healthy children. It’s crucial to have open debates about vaccine safety and efficacy, rather than adhering strictly to consensus. Science evolves, and we should remain open-minded about potential links between vaccines and conditions like autism and schizophrenia, as we still lack definitive answers. Ultimately, it’s about following the science without preconceived notions.

Currently, there is too much convergence between the government, the National Assembly, and the general press, which is unhealthy. There needs to be checks and balances, debates, and many decisions being made are authoritarian and lack scientific substance. For example, forcing people to take an experimental vaccine without giving them a choice is unethical and goes against the principles of medical experimentation. In the future, we will look back and question how such things were allowed to happen. The communication world is starting to collide with reality, whether it's about vaccines or other issues. The vaccines were rushed and not properly evaluated, and there have been adverse effects reported. The number of complaints against the vaccines will continue to rise. It's important to understand the risks and benefits and not exaggerate the severity of the disease.

Behind the scenes communications from the BC Centre for Disease Control revealed that COVID-19 vaccines were 16 times more dangerous than flu shots for children. The data was manipulated before being released to the public, omitting comparisons to flu vaccines and downplaying serious adverse events. This lack of transparency raises concerns about health regulators withholding vital information from the public.

There have been reported side effects of the vaccine, including muscle pain, headaches, feeling unwell, fatigue, and pain at the injection site. It is important to investigate these outbreaks that occur consistently one to two weeks after vaccination. Transparency is crucial, and it is necessary to determine if any deaths are directly related to the vaccination or if there were underlying health conditions. However, there is concern that underlying conditions are often prioritized over the vaccine as the cause of death. This uncertainty raises questions about the accuracy of COVID-19 death statistics. It is crucial to have accurate information about COVID-19 infections and vaccine risks to maintain public trust and promote vaccination. The minister's response to these concerns is seen as alarming and undermines public health.

The symposium covers the potential safety and threat of “replicating” vaccines, especially LepriCon (leprecon) vaccines, in the context of Covid-19 vaccines and genome‑editing concepts. The speakers present a chain of claims and concerns, some drawing on reports and others presenting theories about how these next‑generation vaccines could behave in humans and populations. Key points and claims presented - Emerging mechanisms and risks: The panel notes that blood vessel inflammation and thrombosis mechanisms are increasingly observed, including in vaccine contexts, with examples from individuals who needed limb amputation and others who developed severe vascular events after vaccination. One case involved a 70‑year‑old man who, after a third dose, developed embolic events necessitating shoulder joint surgery, and another where a 60‑year‑old man developed acute limb ischemia and died; both are presented as suggesting a serious vascular mechanism linked to vaccination, though causal connections are not established. - Replicating/vector vaccines and their concerns:荒川博士 and others discuss LepiCon vaccines as vaccines that replicate inside the body. The concept involves “replicating viral vectors” where the genome can mutate and evolve during replication. The green‑highlighted segment in a slide (the antigen gene) plus a blue/orange segment (replicating gene cassette) is used to describe how LepriCon vaccines are designed to carry viral genes and replicate, with the assertion that replication, mutation, and recombination can occur, potentially generating new variants inside the host. - Differences from conventional vaccines: The discussion contrasts LepriCon vaccines with standard mRNA vaccines. In conventional mRNA vaccines, messenger RNA is delivered and translated into antigen proteins, then degraded; in LepriCon vaccines, replicating RNA/DNA can persist and continue producing antigen, with mutation and recombination possible. The panel emphasizes that LepriCon vaccines use replicating/copying mechanisms and that the genetic material can be copied in ways that differ from natural human biology, potentially creating unpredictable variants. - Central dogma and exceptions: The speakers reference the central dogma (DNA → RNA → protein) but note exceptions in viruses, including RNA viruses that can reverse‑transcribe to DNA (retroviruses) and RNA viruses that replicate RNA directly. They discuss how LepriCon vaccines would rely on replicative processes that do not follow the usual linear flow and why this could complicate predictions about safety and behavior in humans. - Potential for unintended spread and environmental impact: A major concern raised is that self‑replicating vectors could spread beyond the vaccinated individual, via exosomes or other intercellular transport, creating secondary infections or non‑target spread. Exosomes could ferry replicating genetic material, raising fears of new infection chains or “outbreaks” stemming from the vaccine itself, and even suggesting the possibility of vaccination‑induced spread akin to an attenuated or modified pathogen. - Safety signals and immunology concerns: The discussion touches on immune system risks, including immune dysregulation, autoimmune phenomena, and unexpected inflammatory responses. IGG4‑related disease is highlighted as a potential adverse outcome post‑vaccination, with descriptions of glandular and systemic involvement and the idea that high IGG4 levels could have immunosuppressive effects that alter responses to infection or vaccination. The panel notes observed increases in certain immunoglobulin subclasses after multiple LepriCon doses and discusses the possibility of immune tolerance or enhanced immune responses that could be harmful. - Historical and theoretical context: References are made to past epidemics and speculative pandemics caused by misused or dangerous vaccine platforms, drawing on central molecular biology concepts and historical anecdotes about how vaccines can be designed and misused. The discussion frames LepriCon vaccines as a high‑risk platform that could, in theory, generate recombinants, escape mutations, or cause unintended immune and inflammatory consequences. - Clinical and regulatory implications: The speakers call for caution, arguing that more evidence is needed before approving or widespread use of LepriCon vaccines. They emphasize the need for long‑term observation and transparent communication about risks, and criticize the potential for insufficient understanding among healthcare workers and the public. They also urge that any future vaccine development should consider the possibility of genome editing, recombination, and exosome‑mediated spread, and stress the importance of not underestimating possible adverse effects. - Real‑world observations and skepticism about hype: Several speakers underscore that the danger is not merely hypothetical; there are reports of adverse events, including stroke‑like conditions, inflammatory diseases, and immune dysregulation in vaccinated individuals. They stress that the evolution and mutation of replicating vaccines could outpace current surveillance methods, and that “information manipulation” or lack of transparent reporting could mislead the public about risks. - Final reflections and call to action: The concluding messages advocate recognizing the potential failures of messenger RNA vaccines and acknowledging that both conventional and replicating platforms may carry risks. The speakers urge ongoing critical analysis, cautious progression, and robust verification of claims through transparent, independent investigation. They close with thanks to the organizers and a hope that the discussion may contribute to broader public awareness and informed decision‑making. Notable emphasis and unique considerations - The core concern centers on LepriCon vaccines’ replication, mutation, and potential to spread beyond the vaccinated person; exosome transport and genomic/cellular integration are highlighted as mechanisms that could generate new risks not present with non‑replicating vaccines. - The discussion stresses that IGG4 responses could become alarmingly high after certain doses, potentially leading to immunosuppressive effects or autoimmune phenomena, and presents IGG4‑related disease as a potential complication to monitor. - The speakers insist that safety and transparency are paramount, and that misinformation or optimistic narratives about rapid vaccine development could lead to harm if new platforms are adopted without comprehensive evaluation. Overall, the symposium foregrounds cautious scrutiny of replicating vaccine platforms, frames potential biological and regulatory risks, and calls for careful, evidence‑based assessment before broader deployment.

No successful coronavirus vaccine has been made. Gene-based vaccines were tested on animals, leading to sickness and death. Despite concerns about safety and lack of long-term data, Canada continued vaccine rollout. A doctor raised safety concerns, was reprimanded for causing vaccine hesitancy, and saw neurological issues in patients post-vaccination. Questions to health authorities went unanswered, leading to a complaint to the College of Physicians and Surgeons.

The discussion centers on concerns about the safety of pediatric vaccines, the governing framework for vaccination and related notifications, and how schools and child-care settings handle cases where vaccination is incomplete. Key points raised by Speaker 0 (in Japanese) include: - The number and variety of pediatric vaccines have been increasing, with regular schedules reaching up to about 30 doses from birth. - Some vaccines include additives such as thiomersal (mercury-containing) and, in the case of influenza vaccines given after six months, thiomersal and aluminum compounds, causing anxiety about brain development and cancer risk. - Thiomersal is described as an organomercury compound that biodegrades to ethylmercury; its linkage to neurodevelopmental disorders has been asserted in materials from the Ministry of Health, Labour and Welfare (MHLW). The materials indicate thiomersal and other additives (e.g., aluminum compounds) can be associated with concerns about cancer risk and memory impairment. The presenter cites materials labeled as current vaccine formulations like “Beugen” (B型肝炎ワクチン) containing thiomersal and organic silver derivatives, and notes concerns about aluminum compounds. - The speaker emphasizes that even with explanations from experts that trace amounts are unlikely to have measurable effects, caregivers remain cautious, influencing decisions about vaccinating their children. - There is a claim that disease risk reduction and broader environmental exposure concerns (e.g., artificial sweeteners, nicotine residues, colorants) contribute to vaccine hesitancy, especially given declining birth rates yet rising incidences of developmental disorders, dementia, or behavior-related conditions. - The speaker asks for the audience’s attention to the confusion surrounding vaccines and their additives, seeking to understand why some guardians opt not to vaccinate. Key organizational questions and clarifications provided by Speaker 1: - Under the Public Health Vaccination Act, local governments issue vaccination recommendations and encourage vaccination, including sending vaccination advisories that specify the timing and method. The notices concern vaccines such as the measles-mumps-rubella (MMR), human papillomavirus (HPV), and Japanese encephalitis vaccines. The advisory notices are not mandatory, but vaccination is strongly encouraged. - When a guardian declines vaccination, it does not constitute abuse or neglect according to the law; preventive services and enforcement do not classify non-vaccination as neglect. Speaker 3 and Speaker 4 address practical and ethical concerns in child-care and education contexts: - In child-care facilities, there is no legal right to label a guardian as neglect simply for non-vaccination, though vaccination status is recorded in health forms. They stress the goal of preventing punitive treatment of guardians and promoting fair, informed medical care for children. - Questions are raised about whether vaccination histories influence admission or screening processes for child-care and school enrollment. The response indicates vaccination status is not a disqualifying factor for admission, and the health information form includes vaccination history; non-vaccinated children should not be disadvantaged in enrollment. - It is acknowledged that some guardians and teachers may hold misconceptions about vaccines, including concerns about toxins. The discussion calls for improved information sharing among health services, childcare, and education officials to reduce misinformation and support informed decisions. Speaker 2 (Takena Kazuko, Head of Childcare Family Division) and Speaker 4 (Ministry or Education official) respond to concerns about information sharing and the role of staff training: - They emphasize the distinction between compulsory vaccination guidance and voluntary advisories, reiterating that withholding vaccination is not automatically considered neglect. - They agree on the need to prevent punitive attitudes toward guardians, to inform teachers and childcare staff about how to communicate vaccine information, and to ensure consistent understanding across health, childcare, and education sectors. - A request is made to improve public awareness so that vaccination decisions are respected and differences in opinion are honored. Overall, the transcript details regulatory mechanisms for vaccination recommendations, the non-punitive stance toward non-vaccination in guardians, and the need for better information sharing and respectful dialogue among public health, childcare providers, and schools to address vaccine hesitancy without resorting to neglect determinations.

A lady in Canada recently held a press conference urging people to get vaccinated and wear masks. The speakers discuss their observations on the vaccine situation, including the loss of jobs for those who choose not to get vaccinated. They mention that the vaccine doesn't prevent transmission or guarantee protection from the virus. They also criticize the use of masks, stating that cloth and surgical masks are ineffective. The speakers express their disbelief and question the lack of scientific evidence supporting these measures. They speculate about the motives behind these decisions.

A $2,000,000 report on Alberta's pandemic response is calling for a halt to COVID-19 vaccines, facing criticism from the Alberta Medical Association as anti-science. The NDP argues the funds could have better supported healthcare, like orthopedic surgeries. The report, authored by 13 doctors and academics, claims COVID-19 infections did not decrease with mask mandates and vaccinations, questioning vaccine safety. Nahed Nenshi urges the premier to clarify her stance on the findings, while the AMA states the report undermines trust in health professionals and overlooks frontline experiences. Experts, including U of A professor Timothy Caulfield, label the report as misinformation. Alberta's health ministry defends the report's purchase, emphasizing the need for diverse perspectives, but offers no commitment to implement its recommendations.

A key insight from the report is the failure to transition from an initial precautionary approach during the pandemic to a more evidence-based strategy that considered risks, benefits, and non-health impacts. This lack of shift has significant implications for public trust. The report highlights insufficient transparency regarding the rationale and evidence behind government decisions that affected Australians' lives and freedoms. Consequently, trust has declined significantly compared to pre-pandemic levels. The panel indicates that many measures implemented during COVID-19 are unlikely to be accepted by the public in the future due to these issues.

Speaker 0 and Speaker 1 discuss the COVID-19 vaccine episode, challenging why the vaccine was pursued as a public health solution and exploring deeper incentives behind the program. - A knowledgeable figure at the stand answered a burning question: did they know the vaccine wouldn’t be effective from the start and could be dangerous? The answer given was that it was “a test of a technology.” The exchange suggests the broader aim was testing an entire program of control previewed in Event 2019. - They ask whether inoculation was necessary on billions, noting it could have been tested on a much smaller population. If shots had been basically empty or inert, the data could have been spun to claim success and end the pandemic, preventing injuries from appearing. The absence of that approach remains a mystery. - The speakers point to high pre-vaccine seroprevalence in 2020, including studies from South Dakota showing 50-60% seroprevalence before vaccine release, implying that a saline shot or no shot could have achieved “indomicity” (immunity) without a vaccine. - They discuss why people might fear vaccines and interpret the broader impact: the public is waking up to something terrible having occurred, as it revealed readiness to lie, potential data quality concerns, and risk to pregnant women and healthy children who might get little justification for risk. - The disease’s lethality is framed as greatest among the very old or very sick; for others, it was less deadly, with natural evolution potentially reducing vulnerability over time. - The mRNA platform was touted as a means to outrun mutations, but the timeline to release was still insufficient to stay ahead of natural change. They note accelerated development was the fastest vaccine in history, from detection to inoculation, reducing the timeline by about a year or two, yet not fast enough. - Political and logistical factors delayed release; there is mention that it would not have appeared under Trump and that Eric Topol argued to delay the rollout. Fauci reportedly sent Moderna back to trials due to insufficient racial diversity in participants. - The discussion questions whether the vaccine qualifies as a normal consumer product, given ongoing subsidies, mandates, indemnifications, wartime-like supports, and propaganda. They wonder if there has been an ongoing two-century revolt by industry against public scrutiny, with public interest repeatedly leading to pushback and rebranding. - A central theme is the sophistication of pharma: the “game of pharma” involves owning an IP-based health claim, crafting supportive research, convincing it is safe and effective, achieving standard-of-care status, securing mandates and government funding, and leveraging ongoing propaganda. They describe pharma as a long-running arms race with deep institutional knowledge, implying that it is far more capable of shaping reality than the public realizes.

- The discussion opens with a critique of how public health authorities in the United States and much of the media discouraged experimentation with COVID-19 treatments, instead pushing vaccination and portraying other approaches as dangerous. The hosts ask why treatments were sidelined and treated as heretical to question. - Speaker 1 explains that the core idea was to stamp out “vaccine hesitation,” which he frames not as a purely scientific issue but as a form of heresy. He notes a broad literature on vaccine hesitancy and contrasts it with the perception of the vaccine as a liberating savior. He points to a Vatican €20 silver coin (2022) commemorating the COVID-19 vaccine, described by Vatican catalogs as “a boy prepares to receive the Eucharist,” which the speakers interpret as an overlay of religious iconography with vaccination imagery. They also reference Diego Rivera’s mural in Detroit, interpreted as depicting the vaccine as a Eucharist, and a South African church banner reading “even the blood of Christ cannot protect you, get vaccinated,” highlighting what they see as provocative uses of religious symbolism to promote vaccination. - They claim that the Biden administration’s COVID Vaccine Corps distributed billions of dollars to major sports leagues (NFL, MLB) and that many mainline churches reportedly received money to push vaccination, with many clergy not opposing the push. The implication is that monetary incentives influenced public figures and organizations to advocate for vaccines, contributing to a climate in which questioning orthodoxy was difficult. - The speakers discuss the social dynamics around vaccine “heresy,” using Aaron Rodgers’ experience with isolation and shaming in the NFL and Novak Djokovic’s experiences in Australia to illustrate how prominent individuals who questioned or fell outside the orthodoxy faced punitive pressure. They compare this to a Reformation-era conflict over doctrinal correctness and describe a psychology of stigmatizing dissent as a tool to enforce conformity. - They argue the imperative driving institutions was the belief that the vaccine was the central, non-negotiable public-health objective, seemingly above other medical considerations. The central question they raise is why vaccines became the sole priority, seemingly overriding a broader, more nuanced evaluation of medical options and individual risk. - The conversation shifts to epistemology and the nature of science. Speaker 1 suggests medicine often relies on orthodoxies and presuppositions, rather than purely empirical processes. He recounts a Kantian view that interpretation depends on preexisting categories, and he uses this to argue that medical decision-making can be constrained by established doctrines, which may obscure questions about optimization and safety. - They recount the 1986 National Childhood Vaccine Injury Act and discuss Sara Sotomayor’s dissent, which argued that liability exposure is a key incentive for safety and improvement in vaccine development. They argue that the current system creates minimal liability for manufacturers, reducing the incentive to optimize safety, and they use this to question how the system encourages continuous safety improvements. - The hosts recount the early-treatment movement led by Peter McCullough and others, including a Senate hearing organized by Ron Johnson in November 2020 to discuss early-treatment options with FDA-approved drugs like hydroxychloroquine. They criticize what they describe as aggressive pushback against such approaches, noting that McCullough faced professional sanctions and lawsuits despite presenting peer-reviewed literature. - They return to the concept of orthodoxy and dogma, arguing that the medical establishment often suppresses dissent, citing YouTube removing a McCullough interview and the broader pattern of silencing challenge to the vaccine narrative. They stress that the social and institutional systems prize conformity and punish those who deviate, creating a climate of distrust toward official health bodies. - The discussion broadens into metaphysical and philosophical territory, with references to the Grand Inquisitor from Dostoevsky’s The Brothers Karamazov. They propose that elites—whether religious, political, or scientific—tend to prefer “taking care” of people through control rather than preserving individual responsibility and free will. The Grand Inquisitor tale is used to illustrate a recurring human temptation: to replace personal liberty with a protected, paternalistic order. - They discuss messenger RNA (mRNA) technology as a central manifestation of Promethean or Luciferian intellect—humans attempting to “read and write in the language of God.” They describe the scientific arc from transcription and translation to mRNA vaccines, noting Francis Collins’s The Language of God and the idea of humans “coding life.” They caution that mRNA vaccines involve injecting genetic material and point to the symbolic and ritual power of vaccination as a form of modern sacrament. - The speakers emphasize that the mRNA approach represents both a profound scientific achievement and a source of deep concern. They discuss fertility signals and potential adverse effects, including myocarditis in young people, and cite the July 2021 NEJM case study as highlighting safety concerns for myocarditis in adolescent males. They reference the FDA deliberative-committee discussions, noting that some influential voices publicly questioned the risk-benefit calculus for young people, yet faced pressure or dismissal within the orthodox framework. - They describe post-hoc investigations and testimonies suggesting that adverse events (like myocarditis) might have been downplayed or obscured, and they assert that public trust in health institutions has eroded as a result. They mention ongoing debates about whether vaccine-induced changes might affect future generations, referencing studies about transcripts of mRNA in cancer cells and liver cells, and they stress the need for independent scrutiny by scientists not “entranced” by the vaccine program. - The dialogue returns to the broader human condition: a tension between curiosity and restraint, knowledge and humility. They return to Dostoevsky’s moral questions about free will, responsibility, and the limits of human knowledge, concluding that scientific hubris can lead to dangerous consequences when it overrides open inquiry and accountability. - In closing, while the guests reflect on past missteps and the need for integrity in medicine, they underscore the ongoing questions about how evidence is interpreted, how dissent is treated, and how society balances scientific progress with humility, transparency, and respect for individual judgment.

A key insight from the report is the failure to transition from an initial precautionary approach during the pandemic to a more evidence-based strategy that balanced risks and benefits, including non-health impacts. This lack of shift has significant implications for public trust. The report highlights insufficient transparency regarding the rationale and evidence behind government decisions, which deeply affected Australians' lives and freedoms. As a result, trust has declined compared to pre-pandemic levels. The panel warns that many measures implemented during COVID-19 are unlikely to be accepted by the public in the future due to this erosion of trust.

A prototype vaccine is being deployed to the public without actually preventing transmission, which is keeping the disease more dangerous than necessary. This is a concerning public health response. The problem is that even if we acknowledge this issue, we don't know how to change it. People tend to believe that public health authorities are doing the right thing because the alternative seems hopeless. It's difficult to discredit them without sounding like they are deliberately harming public health. People find it hard to accept that medical officials in charge of our lives may have bad motivations.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

The Alberta government approved COVID vaccines for children despite no evidence of threat. Unexplained deaths in children are up 350%. One parent shared their daughter's health issues post-vaccination, including mouth and scalp burning, tachycardia, and chronic fatigue. Another parent's son died after receiving the vaccine, experiencing symptoms like vomiting and a rash. Seven months after a child's death, the family still awaits the official cause from the government due to a backlog in investigations.

There is skepticism among the American public about taking the vaccine, and rightfully so. The vaccine may not go through all the necessary tests and trials. If a vaccine is approved and distributed before the election, it raises concerns for everyone. We need access to the vaccine results to ensure there is no political influence. Trust in the federal government's opinion is lacking, and transparency is crucial. The FDA's approval process is not inspiring confidence. We need other experts to review the vaccine and reach a consensus on its safety. There is worry about a potential October surprise and pressure to announce the vaccine. A separate group of doctors will be formed to address these concerns.

We are vaccinating millions, and while there are reports of deaths following vaccinations, there is no evidence that the vaccine causes these deaths. Adverse reactions must be reported, but many go unreported, potentially skewing data. For instance, only 5% of adverse reactions may reach the monitoring database. There have been serious cases, including hospitalizations, that are not being documented properly. Despite the numbers, experts assert that the vaccine is safe and effective. It's crucial for the public to understand that while adverse events will occur, they are often coincidental. The vaccine remains vital for public health, and getting vaccinated is strongly encouraged.

On COVID, there's a perception that credit isn't given where it's due. While the vaccines were developed quickly, they don't prevent infection or transmission and may have serious side effects. In hindsight, would anything be done differently? Studies on the vaccines are ongoing, and results will emerge over time. It's important to note that Pfizer marketed its vaccine as safe for pregnant women, but reports indicated that over half of the 458 pregnant women who received the vaccine experienced adverse events. The ongoing studies will help clarify these concerns.